When less is more: can we abandon prophylactic platelet transfusion in Dengue fever?
Annals of the Academy of Medicine, Singapore
;
: 539-545, 2011.
Artigo
em Inglês
| WPRIM
| ID: wpr-229607
ABSTRACT
Dengue fever (DF) has several hematological manifestations including thrombocytopenia and increased bleeding risk. Prophylactic platelet transfusion-in the absence of major bleeding-is utilized in DF with thrombocytopenia with the intention of preventing hemorrhagic complications. However, prophylactic platelet transfusion in DF is neither standardized nor supported by clinical evidence. We conclude that risks, costs and poor resource utilization associated with prophylactic platelet transfusion in DF far outweigh any potential hematological benefit, and as such, should not constitute routine clinical practice.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Terapêutica
/
Trombocitopenia
/
Transfusão de Plaquetas
/
Dengue
/
Economia
/
Hemorragia
Tipo de estudo:
Avaliação Econômica em Saúde
Limite:
Humanos
Idioma:
Inglês
Revista:
Annals of the Academy of Medicine, Singapore
Ano de publicação:
2011
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS